Separation: As the mixture travels through the column, different molecules interact with the stationary phase to varying degrees
Is IGF-1 LR3 safe to use under medical supervision
A provider can help review: Whether BPC-157 is appropriate for your situation Whether another peptide or regenerative option may be safer Possible medication or health-history concerns Route of use and cycle length Sterility and sourcing concerns Whether follow-up monitoring is needed When to stop, pause, or adjust the plan Medical guidance matters because peptide therapy should be personalized, monitored, and tied to a real treatment goal
Step 1: Preparation Before your first dose: Obtain quality DSIP from a reputable vendor with third-party testing Get appropriate bacteriostatic water , insulin syringes, and alcohol swabs Plan your assessment schedule (which nights you will dose, when you will evaluate) Establish baseline sleep tracking (subjective or with wearable device) Clear any potential interactions (medications, supplements, alcohol plans) Step 2: Assessment phase (weeks 1-2) Reconstitute your DSIP according to the protocols described earlier
Comparing peptides to PRP or stem cell therapy helps patients understand where each fits in a recovery plan